Washington · J7328

Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg in Washington

Washington Medicare Avg
$0.58
7% above national avg
National Medicare Avg
$0.54
All states combined
Billed Charge (WA)
$5.44
What providers submit
Est. Commercial (WA)
$1.75
National avg: $1.55
Est. Cash / Self-Pay (WA)
$2.05
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

43.1K
Services in WA
20
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Washington

Provider Medicare Services
Oros, Vasile PA-C $0.58 16.5K

Washington Pricing in Context

In Washington, CPT code J7328 (Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg) carries an average Medicare payment of $0.58 — 7% above the national benchmark of $0.54. 20 providers across the state submitted claims for this procedure in 2023, performing 43.1K total services. Individual payments in WA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Washington is $5.44, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Washington sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in Washington lands near $1.75, with self-pay cash prices typically around $2.05. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg cost in Washington?

The average Medicare payment for Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg in Washington is $0.58, which is 7% above the national average of $0.54. Providers in WA typically bill $5.44 for this procedure.

What does Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg cost with insurance in Washington?

With commercial insurance in Washington, Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg costs an estimated $1.75. Without insurance, the estimated cash price is $2.05. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg in Washington?

20 providers in Washington billed Medicare for Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg in 2023, performing 43.1K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg cheaper in Washington than the national average?

No — Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg costs 7% above the national average in Washington. The state average Medicare payment is $0.58 compared to $0.54 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial